Your browser is no longer supported. Please, upgrade your browser.
Settings
ELGX Endologix, Inc. daily Stock Chart
ELGX [NASD]
Endologix, Inc.
Index- P/E- EPS (ttm)-0.93 Insider Own1.50% Shs Outstand82.06M Perf Week-7.41%
Market Cap430.82M Forward P/E- EPS next Y-0.47 Insider Trans0.00% Shs Float81.15M Perf Month2.34%
Income-76.80M PEG- EPS next Q-0.20 Inst Own- Short Float15.18% Perf Quarter16.93%
Sales184.60M P/S2.33 EPS this Y-156.40% Inst Trans-3.87% Short Ratio18.37 Perf Half Y8.70%
Book/sh1.02 P/B5.15 EPS next Y20.30% ROA-20.70% Target Price5.44 Perf Year-21.64%
Cash/sh0.91 P/C5.78 EPS next 5Y36.95% ROE-78.80% 52W Range4.08 - 7.66 Perf YTD-8.22%
Dividend- P/FCF- EPS past 5Y-30.30% ROI-32.10% 52W High-31.46% Beta0.74
Dividend %- Quick Ratio2.10 Sales past 5Y18.30% Gross Margin64.70% 52W Low28.68% ATR0.33
Employees782 Current Ratio2.90 Sales Q/Q-11.70% Oper. Margin-30.10% RSI (14)48.08 Volatility6.75% 5.65%
OptionableYes Debt/Eq2.79 EPS Q/Q7.60% Profit Margin-41.60% Rel Volume1.39 Prev Close5.20
ShortableYes LT Debt/Eq2.61 EarningsNov 07 AMC Payout- Avg Volume670.85K Price5.25
Recom2.80 SMA20-2.17% SMA50-0.97% SMA200-2.93% Volume929,751 Change0.96%
Dec-12-17Resumed Piper Jaffray Overweight
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $5 → $4
May-18-17Downgrade Stifel Buy → Hold $10 → $5.50
Nov-17-16Downgrade Canaccord Genuity Buy → Hold $13.50 → $7.50
Nov-16-16Downgrade JP Morgan Overweight → Neutral
Sep-06-16Initiated Leerink Partners Mkt Perform
Aug-03-16Downgrade RBC Capital Mkts Outperform → Sector Perform $17 → $12
Jun-13-16Reiterated RBC Capital Mkts Outperform $15 → $17
May-10-16Reiterated RBC Capital Mkts Outperform $11 → $15
Apr-04-16Resumed JP Morgan Overweight
Feb-23-16Reiterated RBC Capital Mkts Outperform $15 → $11
Feb-02-16Reiterated Stifel Buy $17 → $15
Nov-17-15Reiterated RBC Capital Mkts Outperform $17 → $15
Oct-19-15Initiated RBC Capital Mkts Outperform $17
Aug-06-15Upgrade JP Morgan Neutral → Overweight $17
Aug-04-15Reiterated Stifel Buy $20 → $17
Apr-30-15Reiterated Oppenheimer Perform $15 → $17
Apr-06-15Reiterated Stifel Buy $17 → $20
Oct-01-14Reiterated Stifel Buy $17 → $15
Oct-01-14Reiterated Oppenheimer Perform $15 → $13
Dec-15-17 10:50PM  ENDOLOGIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX PR Newswire
08:00AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : December 15, 2017 Capital Cube
Dec-07-17 01:38PM  ETFs with exposure to Endologix, Inc. : December 7, 2017 Capital Cube
Dec-05-17 09:22AM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017 Capital Cube
Dec-01-17 10:50PM  ENDOLOGIX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX Business Wire
Nov-27-17 09:06PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Endologix, Inc. (ELGX) on Behalf of Shareholders Business Wire
Nov-14-17 04:01PM  Endologix, Inc. to Present at the Piper Jaffray 29th Annual Healthcare Conference Business Wire
Nov-11-17 08:18PM  Edited Transcript of ELGX earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-10-17 01:11PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : November 10, 2017 Capital Cube
Nov-09-17 07:53AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : November 9, 2017 Capital Cube
Nov-07-17 04:51PM  Endologix reports 3Q loss Associated Press -7.84%
04:01PM  Endologix Reports Third Quarter 2017 Financial Results Business Wire
10:10AM  Endologix, Inc. to Host Earnings Call ACCESSWIRE
06:53AM  NasdaqGS Healthcare Industry: A Deep Dive Into Endologix Inc (ELGX) Simply Wall St.
Nov-01-17 04:01PM  Endologix Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire +5.09%
Oct-30-17 04:51PM  Is Endologix Inc (ELGX) A Financially Sound Company? Simply Wall St.
Oct-27-17 10:52AM  ETFs with exposure to Endologix, Inc. : October 27, 2017 Capital Cube
Oct-26-17 04:01PM  Endologix, Inc. to Present at the Stifel 2017 Healthcare Conference Business Wire
Oct-19-17 08:00AM  Endologix Appoints John Onopchenko as Chief Operating Officer Business Wire
Oct-16-17 03:37PM  What Does Endologix Incs (ELGX) Share Price Indicate? Simply Wall St.
Oct-10-17 04:01PM  Endologix, Inc. to Announce Third Quarter 2017 Financial Results on November 7, 2017 Business Wire
Oct-06-17 08:00AM  Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix® EndoVascular Aneurysm Sealing System Business Wire
Oct-03-17 11:11AM  ETFs with exposure to Endologix, Inc. : October 3, 2017 Capital Cube +20.62%
Sep-30-17 04:02PM  What Are The Drivers Of Endologix Incs (ELGX) Risks? Simply Wall St.
Sep-27-17 08:00AM  Endologix, FDA Delays Nellix EVAS in May, Guidance and Pipeline Review ACCESSWIRE
Sep-22-17 11:10AM  ETFs with exposure to Endologix, Inc. : September 22, 2017 Capital Cube
Sep-21-17 12:57PM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017 Capital Cube
08:00AM  Endologix Announces CE Mark Approval for the Nellix® EndoVascular Aneurysm Sealing System with the Refined Indications for Use Business Wire
Sep-13-17 08:31PM  Is There Now An Opportunity In Endologix Inc (ELGX)? Simply Wall St.
Sep-11-17 08:00AM  Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Commercialization of Thoracic Endovascular Systems in Japan Business Wire
Aug-17-17 08:00AM  Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study Business Wire
Aug-15-17 05:44PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : August 15, 2017 Capital Cube
Aug-12-17 08:30PM  Edited Transcript of ELGX earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-17 04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
Aug-02-17 10:59PM  Endologix reports 2Q loss Associated Press
04:01PM  Endologix Reports Second Quarter 2017 Financial Results Business Wire
10:20AM  Investor Network: Endologix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 09:15AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : August 1, 2017 Capital Cube
Jul-12-17 04:01PM  Endologix, Inc. to Announce Second Quarter 2017 Financial Results on August 2, 2017 Business Wire
Jul-10-17 04:01PM  Endologix, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference Business Wire
Jul-03-17 02:55PM  Lifshitz & Miller LLP Announces Investigation of Aaron's, Inc., Axiom Holdings, Inc., Booz Allen Hamilton Holding Corporation, CenturyLink, Inc., Endologix, Inc., Sky Solar Holdings, Ltd. and Rightside Group, Ltd. PR Newswire
Jun-13-17 08:33AM  ENDOLOGIX ALERT: J&W Investigates Endologix, Inc.; Long Term Investors Encouraged to Contact the Firm PR Newswire
Jun-12-17 12:47PM  Robbins Arroyo LLP: Endologix, Inc. (ELGX) Misled Shareholders According to a Recently Filed Class Action Business Wire
Jun-03-17 12:00PM  Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial Business Wire
Jun-01-17 04:19AM  Endologix Reports Positive Clinical Data from the Ovation LUCY Study with 1.3% Major Adverse Event Benzinga
May-31-17 09:30PM  Endologix Reports Positive Clinical Data from the Ovation LUCY Study Business Wire
May-26-17 01:06PM  ETFs with exposure to Endologix, Inc. : May 26, 2017 Capital Cube
12:09PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. ELGX Business Wire
May-19-17 08:00AM  Today's Research Reports on Stocks to Watch: GlycoMimetics and Endologix Accesswire
May-18-17 12:30PM  Why Endologix Shares Are Hitting a Multiyear Low 24/7 Wall St. -36.70%
11:20AM  Why Endologix, Inc. Is Getting Crushed Today Motley Fool
May-17-17 04:45PM  Endologix Provides an Update on the Nellix® Endovascular Aneurysm Sealing System U.S. Regulatory Status Business Wire
May-16-17 08:16AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : May 16, 2017 Capital Cube
May-11-17 04:35PM  ETFs with exposure to Endologix, Inc. : May 11, 2017 Capital Cube
May-10-17 08:46AM  Edited Transcript of ELGX earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 11:44AM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-04-17 05:14PM  Endologix reports 1Q loss Associated Press
04:01PM  Endologix Reports First Quarter 2017 Financial Results Business Wire
May-02-17 08:37AM  Implied Volatility Surging for Endologix (ELGX) Stock Options Zacks
May-01-17 04:38PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. - ELGX PR Newswire
Apr-24-17 04:01PM  Endologix, Inc. to Host an Investor Conference Call to Discuss its Nellix® Endovascular Aneurysm Sealing System Presentation at the Society of Vascular Surgery Annual Meeting on June 3, 2017 Business Wire
03:19PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : April 24, 2017 Capital Cube
Apr-21-17 08:46AM  Endologix, Inc. breached its 50 day moving average in a Bullish Manner : ELGX-US : April 21, 2017 Capital Cube
Apr-17-17 04:01PM  Endologix, Inc. to Announce First Quarter 2017 Financial Results on May 4, 2017 Business Wire
Apr-05-17 11:47AM  [$$] Deerfield Management Invests Up to $170 Million in Endologix The Wall Street Journal
11:47AM  [$$] Deerfield Management Invests Up to $170 Million in Endologix
08:23AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : April 5, 2017 Capital Cube
08:23AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : April 5, 2017
Apr-04-17 06:00PM  Endologix Enters into $170 Million Credit Facility with Deerfield Management Business Wire -7.24%
06:00PM  Endologix Enters into $170 Million Credit Facility with Deerfield Management
Mar-31-17 07:00AM  Endologix, Inc. Announces Enrollment of First Patients in ELEVATE IDE Clinical Study Business Wire
Mar-28-17 09:41AM  Endologix Poised for a Potentially Volatile Breakout TheStreet.com
09:41AM  Endologix Poised for a Potentially Volatile Breakout
Mar-23-17 08:14AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : March 23, 2017 Capital Cube
08:14AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : March 23, 2017
Mar-17-17 01:49PM  5 Stocks Trending Close to Major Breakouts TheStreet.com
01:49PM  5 Stocks Trending Close to Major Breakouts
Mar-13-17 04:01PM  Endologix, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference Business Wire
Mar-09-17 02:28PM  Columbia Wanger Buys LCI Industries, Nasdaq GuruFocus.com
02:28PM  Columbia Wanger Buys LCI Industries, Nasdaq
07:32AM  Endologix, Inc. breached its 50 day moving average in a Bullish Manner : ELGX-US : March 9, 2017
Mar-07-17 01:04PM  ENDOLOGIX INC /DE/ Financials
Mar-06-17 10:58AM  DEADLINE TODAY FOR ELGX INVESTORS: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-03-17 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endologix, Inc. of Class Action Lawsuit and Upcoming Deadline - ELGX Accesswire
11:29AM  EGLX UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endologix, Inc. and a Lead Plaintiff Deadline of March 6, 2017 GlobeNewswire
Mar-02-17 06:52PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endologix, Inc. - ELGX PR Newswire
Mar-01-17 04:41PM  ENDOLOGIX INC /DE/ Files SEC form 10-K, Annual Report
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endologix Inc. (ELGX) and Lead Plaintiff Deadline: March 6, 2017 GlobeNewswire
Feb-27-17 03:33PM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:26PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The March 6, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Endologix Inc. To Contact The Firm Business Wire
12:40PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:06PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endologix, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 6, 2017 ELGX GlobeNewswire
12:04PM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27, 2017
10:42AM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-26-17 11:25PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Endologix, Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
Feb-24-17 09:14PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Endologix, Inc. and Certain Officers ELGX GlobeNewswire
01:17PM  5 Stocks Set for Explosive Breakouts
10:26AM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endologix, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-23-17 11:40PM  Pawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Endologix Inc.- ELGX Accesswire
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. It offers minimally-invasive endovascular repair (EVAR) products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the ovation abdominal stent graft system. The company also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, it offers proximal aortic extensions and limb extensions, which attach to the main body of its EVAR device, allowing physicians to customize it to fit the patient's anatomy; and accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, inflation devices, and snares. The company offers its EVAR products under Powerlink System, IntuiTrak, AFX, VELA Proximal Endograft brand names; and EVAS products under the Nellix EVAS system brand name. It sells its products through direct sales force, network of agents, and independent distributors or agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zenty III Thomas FDirectorMay 22Buy4.445,00022,20046,574May 24 11:21 AM
Lemaitre DanDirectorMay 22Buy4.4322,52299,77268,689May 23 11:06 AM
McDermott John DChief Executive OfficerMay 19Buy4.4525,000111,250657,169May 30 01:03 PM
NEELS GUIDO JDirectorMay 19Buy4.3220,00086,40061,380May 23 10:56 AM
Mitchell Robert DPresidentMay 19Buy4.322,2009,504315,699May 22 05:51 PM